Metabolon Revenue and Competitors

Location

$159.7M

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Metabolon's estimated annual revenue is currently $69.4M per year.(i)
  • Metabolon's estimated revenue per employee is $217,000
  • Metabolon's total funding is $159.7M.

Employee Data

  • Metabolon has 320 Employees.(i)
  • Metabolon grew their employee count by -1% last year.

Metabolon's People

NameTitleEmail/Phone
1
CSOReveal Email/Phone
2
VP, Technology and AIReveal Email/Phone
3
VP OperationsReveal Email/Phone
4
VP, Global Head SalesReveal Email/Phone
5
VP, Corporate DevelopmentReveal Email/Phone
6
VP, Global Head Human ResourcesReveal Email/Phone
7
Senior Director, Financial Planning and AnalysisReveal Email/Phone
8
Study Director, AcademicReveal Email/Phone
9
DirectorReveal Email/Phone
10
Director, Discovery and Translational SciencesReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$11.2M72-13%N/AN/A
#2
$5099.8M32902-4%N/AN/A
#3
$1.7M110%N/AN/A
#4
$0.6M4-56%N/AN/A
#5
$0.9M11-39%N/AN/A
#6
$1.7M1110%N/AN/A
#7
$0.6M4-33%N/AN/A
#8
$4.8M31-6%N/AN/A
#9
$6.4M413%N/AN/A
#10
$4.2M27-18%N/AN/A
Add Company

What Is Metabolon?

Metabolon has quickly become a leader in the application of metabolomics to design novel therapies. Located in Research Triangle Park, North Carolina, Metabolon is based in a biotechnology epicenter. We are leaders in the use of metabolomic technology, initially focusing on drug development and treatment for ALS. In collaboration with Massachusetts General Hospital, our program has identified biomarkers for the disease and for the action of Rilutek®, an Aventis drug for the treatment of ALS.

keywords:Biotechnology

$159.7M

Total Funding

320

Number of Employees

$69.4M

Revenue (est)

-1%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Metabolon News

2020-09-23 - Metabolon Announces $72 Million in Debt and Equity Financing

Metabolon, Inc., the global leader in metabolomics solutions advancing drug development and precision medicine, today announced the close on $72 million in combined debt and equity financing. This round of financing included Perceptive Advisors as a new participant. EW Healthcare Partners and ot ...

2020-09-23 - Metabolon, Inc. : Announces $72 Million in Debt and Equity Financing to Accelerate Advancements in Precision Medicine and Innovative Drug Development Technologies

MORRISVILLE, N.C., Sept. 23, 2020 /PRNewswire/ -- Metabolon, Inc., the global leader in metabolomics solutions advancing drug development and precision medicine, today announced the close on $72 million in combined debt and equity financing. This round of financing included Perceptive Advisors a ...

2020-09-23 - Metabolon Closes $72 Million in Debt and Equity Financing

Metabolon, Inc., the global leader in metabolomics solutions advancing drug development and precision medicine, today announced the close on $72 million in combined debt and equity financing. This round of financing included Perceptive Advisors as a new participant. EW Healthcare Partners and ot ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$111M3298%N/A
#2
$75M41661%N/A
#3
$91.6M422-14%$179.1M
#4
$69.7M4299%N/A
#5
$97M4310%N/A